An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

Author(s): Stahl, M; Abdel-Wahab, O; Wei, AH; Savona, MR; Xu, ML; Xie, Z; Taylor, J; Starczynowski, D; Sanz, GF; Sallman, DA; Santini, V; Roboz, GJ; Patnaik, MM; Padron, E; Odenike, O; Nazha, A; Nimer, SD; Majeti, R; Little, RF; Gore, S; List, AF; Kutchroo, V; Komrokji, RS; Kim, TK; Kim, N; Hourigan, CS; Hasserjian, RP; Halene, S; Griffiths, EA; Greenberg, PL; Figueroa, M; Fenaux, P; Efficace, F; DeZern, AE; Della Porta, MG; Daver, NG; Churpek, JE; Carraway, HE; Brunner, AM; Borate, U; Bennett, JM; Bejar, R; Boultwood, J; Loghavi, S; Bewersdorf, JP; Platzbecker, U; Steensma, DP; Sekeres, MA; Buckstein, RJ; Zeidan, AM;
Details: Publication Year 2023-06-27,Volume 7,Issue #12,Page 2709-2714
Journal Title: Blood Advances
Publisher: ASH
Keywords: Humans; Myelodysplastic Syndromes/diagnosis/therapy; Chromosome Aberrations
Research Division(s): Blood Cells And Blood Cancer
PubMed ID: 36260702
Publisher's Version: https://doi.org/10.1182/bloodadvances.2022008747
Open Access at Publisher's Site: https://doi.org/10.1182/bloodadvances.2022008747
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2023-06-30 02:16:23

Last Modified: 2023-06-30 03:06:11